U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Interleukin-2 receptor subunit beta and gamma complex
DN82J7Z829
Other
General
Record Details
Names
2
Identifiers
3
Subunits
2
Disulfide Links
5
Glycosylation
11
Relationships
3
Modifications
1
Characteristic Attributes
2
Interleukin-2 receptor subunit beta and gamma complex
DN82J7Z829
Other
General
Approval Year
Unknown
149,124
Record Details
Substance Class
Protein
Protein Type
RECEPTOR
Protein Sub Type
CYTOKINE RECEPTOR
Sequence Origin
HUMAN
Sequence Type
COMPLETE
Record UNII
DN82J7Z829
Record Status
Validated (UNII)
Record Version
12
11
10
9
8
7
6
5
4
3
2
1
Names
2
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
IL-2 receptor beta and gamma subunits
Preferred Name
English
Interleukin-2 receptor subunit beta and gamma complex
Common Name
English
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
3
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
DN82J7Z829
PRIMARY
UNIPROT
P14784
PRIMARY
UNIPROT
P31785
PRIMARY
Showing 1 to 3 of 3 entries
Previous
1
Next
Subunits
2
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Disulfide Links
5
Show
5
20
100
All
entries
From
To
From
To
1_48
1_60
1_33
1_84
2_160
2_209
2_80
2_93
2_40
2_50
Showing 1 to 5 of 5 entries
Previous
1
Next
Glycosylation
11
Glycosylation Type
HUMAN
Show
5
20
100
All
entries
Glycosylation Link Type
Site
Glycosylation Link Type
Site
N
1_3
N
1_17
N
1_45
N
1_123
N
1_326
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Relationships
3
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
D83KB6PH3Y
Efzilonkofusp Alfa
LIGAND->TARGET
Amount:
3Y7ANB3DKG
Efdelikofusp Alfa
LIGAND->TARGET
Amount:
S4NL6N7DWD
SHR-1501
AGONIST -> TARGET
Comments:
SHR-1501 activates and increases the levels of natural killer (NK) cells and memory CD8+ T-cells without stimulating regulatory T-cells (Tregs).
Amount:
Showing 1 to 3 of 3 entries
Previous
1
Next
Modifications
1
Structural Modifications
Show
5
20
100
All
entries
Modification Type
Location Site
Location Type
Residue Modified
Extent
Fragment Name
Fragment Approval
Modification Type
Location Site
Location Type
Residue Modified
Extent
Fragment Name
Fragment Approval
AMIDIFICATION
[2_279]
SITE_SPECIFIC
THREONINE PHOSPHATE
3L4WX7B1EI
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Molecular Formula
CHEMICAL
ESTIMATED
C4420H6673N1174O1312S31
MOL_WEIGHT:NUMBER(CALCULATED)
CHEMICAL
ESTIMATED 98268.97 Da (average)
Showing 1 to 2 of 2 entries
Previous
1
Next
